
Kemar E. Green, DO, FANA
Kemar E. Green, DO, FANA, is a rare and complex disease neurologist with subspecialty expertise in neuro-opthalmology and neuro-otology. He is the founder and CEO of NeuroAgent AI, Inc. and HazyEyes, Inc., leading the development of AI-driven, autonomous neurodiagnostic and monitoring platforms. He remains affiliate faculty at the Johns Hopkins Data Science & AI Institute (DSAI), serves as a clinical mentor for Johns Hopkins Biomedical Engineering Undergraduate Design and Precision Care Medicine Design teams, and is a fellow of the American Neurological Association.

Logan Hazellief
Logan Hazellief is the digital and brand strategist at the PAN Foundation, an independent nonprofit dedicated to accelerating access to affordable, equitable healthcare through financial assistance, advocacy, and education. In this role, she oversees the organization’s digital presence, including social media and branding initiatives. Passionate about healthcare, Logan draws inspiration from personal experiences supporting family members with chronic conditions.

James F. Howard, Jr. MD, FAAN
James F. Howard, Jr. MD, FAAN, is a professor of neurology (neuromuscular disorders), medicine, and allied health at UNC Chapel Hill School of Medicine. A practicing neurologist for 46 years, he is the author of more than 250 works on MG. He currently directs the Myasthenia Gravis Clinical Trials and Translational Research Unit at UNC, where he has been the global lead investigator for several of the only approved therapeutics for MG.

Kevin Mack, MA, LPC
Kevin R. Mack, MA, LPC, is the founder and CEO of Mack Counseling, a Houston-based behavioral health organization that provides support to individuals with MG and their caregivers through the MGFA Helpline. Not long after forging this partnership, his own son was diagnosed with MG. MGFA became more than a partner organization — it became a source of guidance, connection, and trusted support for his family during a critical time.

Carlos Ortiz
Hailing from Queens, NY, Carlos Ortiz dedicates his work with the MGFA to his father, whose life was profoundly changed by myasthenia gravis. Through advocacy and fundraising, Carlos’ goal is to continue ‘moving the needle’ for the MG community and ensure patients receive the recognition and support they deserve. Carlos is honored to stand by his father’s side, supporting him through every step and challenge of his MG journey. Carlos is an MGFA ambassador, co-chairs the MG Walk New York, and received the 2025 Emerging Leader of the Year Award.

Gülşen Öztosun, MD
Gülşen Öztosun, MD, earned her medical degree from Acıbadem University School of Medicine, where she was awarded a full academic scholarship. She is a physician by training and serves as a clinical research associate at The George Washington University School of Medicine and Health Sciences in the Department of Neurology and Rehabilitation Medicine. Her work involves supporting clinical research in neurological and neuromuscular conditions, particularly myasthenia gravis. More recently, she has been involved in projects exploring how artificial intelligence may help improve the diagnosis, monitoring. and management of MG.

Pat Reynolds
Pat Reynolds is a retired RN and adult psychiatric mental health nurse practitioner. She graduated from the University of Arizona College of Nursing with bachelor’s and master’s degrees in nursing. Pat relies on her holistic nursing framework to guide her role as a caregiver to her husband and other family members. She is an avid lifelong learner and outdoor enthusiast.

Michael Rosario-Prieto, MD
Michael Rosario-Prieto, MD, is a neuromuscular specialist at BayCare Neurology Group, the medical director for the Tampa Bay Muscular Dystrophy Care Center, and the team neurologist for the Tampa Bay Rays. He completed his medical training at New York Medical College and a neurology residency at University of Connecticut in 2012, where his interest in neuromuscular diseases was seeded. After fellowships at Duke University, he moved to Florida, where he has been treating patients and active in clinical trials for over a decade.

Tuan Vu, MD
Tuan Vu, MD, is a professor of neurology and the director of the Neuromuscular Division and Electromyography Laboratories at the University of South Florida Morsani College of Medicine. In addition to providing expert care to patients with neuromuscular diseases for more than 30 years and teaching neurophysiology and neuromuscular medicine, Dr. Vu is extensively involved in MG clinical trials and has also participated in numerous ALS, CIDP, and myositis/myopathy trials.

Sarah Wright, DO
Sarah Wright, DO, serves as the neuromuscular program director at Children’s National Hospital in Washington, D.C., where she cares for children and young adults with both hereditary and acquired nerve and muscle disorders. Dr. Wright’s research interests include novel therapeutic targets for Duchenne muscular dystrophy and juvenile myasthenia gravis.
